Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Friedberg

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Harefuah|August 1, 1996
[Hypochondriasis in the elderly]A Yoffe, G Friedberg
Annals of Internal Medicine|December 1, 1982
Naloxone and ethanol intoxicationJ M Guerin, G Friedberg
Journal of Palliative Care|December 1, 1988
Management of AIDS-related infections with an accent on outpatient therapy and prophylaxisG Friedberg, A E Glatt
Journal - American Intra-Ocular Implant Society|April 1, 1980
External application of an irrigating lens loop for extracapsular cataract extractionJ H Sheets, J G Friedberg
Neurology|May 5, 1999
Psychosis: impact on the patient and familyE Melamed, G Friedberg, J Zoldan
Archives of Ophthalmology (Chicago, Ill. : 1960)|February 1, 1980
Vitreous wick syndrome following discission of the posterior capsuleJ H Sheets, J G Friedberg
Advances in Neurology|January 1, 1996
Ondansetron, a 5-HT3 antagonist for visual hallucinations and paranoid delusional disorder associated with chronic L-DOPA therapy in advanced Parkinson's diseaseJ Zoldan, G Friedberg, A Weizman, et al.
Neurology|July 1, 1995
Psychosis in advanced Parkinson's disease: treatment with ondansetron, a 5-HT3 receptor antagonistJ Zoldan, G Friedberg, M Livneh, et al.
Clinical Neuropharmacology|October 28, 1998
Parkinson Psychosis Rating Scale: a practical instrument for grading psychosis in Parkinson's diseaseG Friedberg, J Zoldan, A Weizman, et al.
Lancet (London, England)|February 27, 1993
Ondansetron for hallucinosis in advanced Parkinson's diseaseJ Zoldan, G Friedberg, H Goldberg-Stern, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Harefuah|August 1, 1996
[Hypochondriasis in the elderly]A Yoffe, G Friedberg
Annals of Internal Medicine|December 1, 1982
Naloxone and ethanol intoxicationJ M Guerin, G Friedberg
Journal of Palliative Care|December 1, 1988
Management of AIDS-related infections with an accent on outpatient therapy and prophylaxisG Friedberg, A E Glatt
Journal - American Intra-Ocular Implant Society|April 1, 1980
External application of an irrigating lens loop for extracapsular cataract extractionJ H Sheets, J G Friedberg
Neurology|May 5, 1999
Psychosis: impact on the patient and familyE Melamed, G Friedberg, J Zoldan
Archives of Ophthalmology (Chicago, Ill. : 1960)|February 1, 1980
Vitreous wick syndrome following discission of the posterior capsuleJ H Sheets, J G Friedberg
Advances in Neurology|January 1, 1996
Ondansetron, a 5-HT3 antagonist for visual hallucinations and paranoid delusional disorder associated with chronic L-DOPA therapy in advanced Parkinson's diseaseJ Zoldan, G Friedberg, A Weizman, et al.
Neurology|July 1, 1995
Psychosis in advanced Parkinson's disease: treatment with ondansetron, a 5-HT3 receptor antagonistJ Zoldan, G Friedberg, M Livneh, et al.
Clinical Neuropharmacology|October 28, 1998
Parkinson Psychosis Rating Scale: a practical instrument for grading psychosis in Parkinson's diseaseG Friedberg, J Zoldan, A Weizman, et al.
Lancet (London, England)|February 27, 1993
Ondansetron for hallucinosis in advanced Parkinson's diseaseJ Zoldan, G Friedberg, H Goldberg-Stern, et al.
Pageof 2